General Information of the Compound
| Compound ID |
CP0041831
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester
Show/Hide
|
||||||||||||||||||
| Synonyms |
ATROMID-S (TN)
AY 61123
AY-61123
Amotril
Amotril S
Angiokapsul
Anparton
Antilipid
Antilipide
Apolan
Arterioflexin
Arterosol
Artevil
Ateculon
Ateriosan
Athebrate
Atheromide
Atheropront
Athranid-wirkstoff
Athromidin
Atrolen
Atromid
Atromid S
Atromid-S
Atromid-S (TN)
Atromid-S, Clofibrate
Atromida
Atromidin
Atrovis
Azionyl
BML2-F02
Bioscleran
Bresit
C 6643
CPIB
Cartagyl
Chlorfenisate
Chlorophenoxyisobutyrate, Ethyl
Chlorphenisate
Cinnarizin
Citiflus
Claripex
Claripex CPIB
Cloberat
Clobrat
Clobren-5F
Clobren-SF
Clofar
Clofibate
Clofibram
Clofibrat
Clofibrate
Clofibrate (CLOF)
Clofibrate (JP15/USP/INN)
Clofibrate [USAN:INN:BAN:JAN]
Clofibrato
Clofibrato [INN-Spanish]
Clofibrato [Spanish]
Clofibratum
Clofibratum [INN-Latin]
Clofibric Acid, Ethyl Ester
Clofinit
Clofipront
Delipid
Deliva
Dura clofibrat
ELPI
EPIB
Ethyl 2-(4-chlorophenoxy)isobutyrate
Ethyl 2-(p-chlorophenoxy)isobutyrate
Ethyl alpha-(4-chlorophenoxy)isobutyrate
Ethyl alpha-(p-chlorophenoxy)isobutyrate
Ethyl alpha-p-chlorophenoxyisobutyrate
Ethyl chlorophenoxyisobutyrate
Ethyl clofibrate
Ethyl p-chlorophenoxyisobutyrate
Ethyl para-chlorophenoxyisobutyrate
Ethyl-alpha-p-chlorophenoxy-isobutyrate
Fibralem
Gerastop
Hyclorate
Klofibrat
Klofiran
Levatrom
Lipamid
Lipavil
Lipavlon
Lipide 500
Lipidsenker
Lipofacton
Lipomid
Liponorm
Liporeduct
Liporil
Liposid
Liprin
Liprinal
Lobetrin
Miscleron
Misclerone
Miskleron
Negalip
Neo-Atomid
Neo-Atromid
Normalip
Normat
Normet
Normolipol
Novofibrate
Oxan 600
Persantinat
Recolip
Regardin
Regelan
Regelan N
Robigram
Scrobin
Serofinex
Serotinex
Skerolip
Sklerepmexe
Sklero
Sklero-Tablinen
Sklero-tablinene
Sklero-tabuls
Sklerolip
Skleromex
Skleromexe
Ticlobran
Vincamin compositum
Xyduril
Yoclo
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H15ClO3
|
||||||||||||||||||
| Molecular Weight |
242.702
|
||||||||||||||||||
| Canonical SMILES |
CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
KNHUKKLJHYUCFP-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
637-07-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound